Genes in MS Patients Franklin Square NY

Two genes in mice have been linked to improvements in the body's ability to repair itself when afflicted with multiple sclerosis, potentially leading to more effective treatments, a U.S. scientist reports. "Most MS genetic studies have looked at disease susceptibility -- or why some people get MS and others do not," study author Allan Bieber, a Mayo Clinic neuroscientist, said in a Mayo news release.

Local Companies

Dr. Steven Diamant, DC PC
(646) 626-7893
515 Madison Ave
New York, NY
George Lazarou
(718) 294-7104
1770 Grand Concourse #1L
Bronx, NY
Beatrice Seff
(718) 626-3414
95 Chester Ave
Brooklyn, NY
Elzbieta Sawickizka
(718) 359-1413
14610 56th Rd
Flushing, NY
Alpert Scott
(631) 423-4090
33 Walt Whitman Rd
Huntington Station, NY
Carlos Alcorta
(201) 869-3737
1009 79Th St
North Bergen, NJ
Matthew B. Lubin, MD
877-GENES-MD
983 Park Avenue
New York, NY
Jacob Esses
(718) 863-8030
2590 Frisby Ave
Bronx, NY
Joseph Ahram
(718) 963-6484
374 Stockholm St #1 North
Brooklyn, NY
Constance Stewart
(516) 766-2199
63-110 Woodhaven Blvd.
Rego Park, NY
Data Provided by:
  

Provided By:

FRIDAY, Sept. 11 (HealthDay News) -- Two genes in mice have been linked to improvements in the body's ability to repair itself when afflicted with multiple sclerosis, potentially leading to more effective treatments, a U.S. scientist reports.

"Most MS genetic studies have looked at disease susceptibility -- or why some people get MS and others do not," study author Allan Bieber, a Mayo Clinic neuroscientist, said in a Mayo news release. "This study asked, among those who have MS, why do some do well with the disease while others do poorly, and what might be the genetic determinants of this difference in outcome."

The study, which was scheduled to be presented Friday at the Congress of the European Committee for Treatment and Research in Multiple Sclerosis in Dusseldorf, Germany, identified two genes that appear to lead to repair of damage caused by multiple sclerosis in mice.

Multiple sclerosis affects about 330,000 people in the United States. The disease targets the central nervous system and damages the insulation that covers nerves. People with the disease suffer from a variety of symptoms, including loss of strength, vision, balance and muscle coordination.

"It's possible that the identification of these genes may provide the first important clue as to why some patients with MS do well, while others do not," Bieber said in the news release.

More information

Learn more about the disease from the National Multiple Sclerosis Society.

SOURCE: Mayo clinic, news release, Sept. 11, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Related Articles
- Genetic Clues for Skin Cancer Therapies Franklin Square NY
Scientists have isolated a group of genetic mutations involved in the growth of melanoma, the deadliest form of skin cancer. Their work may lead to therapies with existing drugs that target the same mutations. Led by Yardena Samuels of the National Human Genome Research Institute, the research team from the U.S. National Institutes of Health (NIH) sequenced the protein tyrosine kinase (PTK) gene family in tumor and blood samples from people with metastatic melanoma.
- Gene Therapy for Parkinson's Franklin Square NY
- Depression in Heart Disease Patients Franklin Square NY
- Doctor-Patient Talk for Hypertension Franklin Square NY
- Side Effect Of Chemotherapy Drugs Franklin Square NY
- High Blood Pressure Genes Franklin Square NY
- Differences Between Hospice and Palliative Care Franklin Square NY
- Gene Variants and Alzheimer's Risk Franklin Square NY
- Hospice: Getting Back Control of Your Life Franklin Square NY
- Exercise for Chemotherapy Patients Franklin Square NY